<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Distal muscular dystrophies/myopathies</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Distal muscular dystrophies/myopathies</h1>
<div class="graphic"><div class="figure"><div class="ttl">Distal muscular dystrophies/myopathies</div><div class="cntnt"><table cellspacing="0"><colgroup span="7" width="14%"></colgroup> <tbody> <tr> <td class="subtitle1">Type</td> <td class="subtitle1">Inheritance</td> <td class="subtitle1">Usual age of onset (years)</td> <td class="subtitle1">Initial weakness</td> <td class="subtitle1">Serum creatine kinase</td> <td class="subtitle1"> <p>Muscle</p> <p>biopsy</p> </td> <td class="subtitle1">Locus/gene</td> </tr> <tr> <td>Nonaka distal myopathy (hereditary inclusion body myopathy*)</td> <td>Autosomal recessive or sporadic</td> <td>15 to 20</td> <td>Legs: anterior compartment</td> <td>Slightly to moderately increased, usually &lt;10 times normal</td> <td>Myopathic with rimmed vacuoles</td> <td> <p>9p13.3</p> GNE</td> </tr> <tr> <td>Miyoshi muscular dystrophy 1 (LGMD R2<sup>¶</sup>)</td> <td>Autosomal recessive or sporadic</td> <td>&lt;20</td> <td>Legs: posterior compartment</td> <td>Increased 10 to 100 times normal</td> <td>Myopathic, usually without vacuoles; gastrocnemius often "end stage"</td> <td> <p>2p13.3</p> DYSF</td> </tr> <tr> <td>Miyoshi muscular dystrophy 3 (LGMD R12<sup>Δ</sup>)</td> <td>Autosomal recessive</td> <td>&gt;20</td> <td>Legs: posterior compartment</td> <td>Increased 20 to 50 times normal</td> <td>Myopathic</td> <td> <p>11p14.3</p> ANO5</td> </tr> <tr> <td>Welander distal myopathy</td> <td>Autosomal dominant</td> <td>&gt;40</td> <td>Hands: fingers and wrist extensors</td> <td>Normal or slightly increased</td> <td>Myopathic; rimmed vacuoles in some cases</td> <td> <p>2p13</p> TIA1</td> </tr> <tr> <td>Udd distal myopathy</td> <td>Autosomal dominant</td> <td>&gt;35</td> <td>Legs: anterior compartment</td> <td>Normal or slightly increased</td> <td>Vacuolar myopathy</td> <td> <p>2q31</p> TTN</td> </tr> <tr> <td>Markesbery-Griggs late onset distal myopathy</td> <td>Autosomal dominant</td> <td>&gt;40</td> <td>Legs: anterior compartment</td> <td>Normal or slightly increased</td> <td>Vacuolar and myofibrillar myopathy</td> <td> <p>10q22.3-q23.2</p> LDB3</td> </tr> <tr> <td>Distal myotilinopathy</td> <td>Autosomal dominant</td> <td>&gt;40</td> <td>Legs: posterior &gt; anterior compartment</td> <td>Slightly increased</td> <td>Vacuolar and myofibrillar myopathy</td> <td> <p>5q31</p> MYOT</td> </tr> <tr> <td>Laing distal myopathy (MPD1)</td> <td>Autosomal dominant</td> <td>&lt;20</td> <td>Legs: anterior compartment; neck flexors</td> <td>Slightly increased to ≤3 times normal</td> <td>Moderate myopathic changes; no vacuoles</td> <td> <p>14q12</p> MYH7</td> </tr> <tr> <td>Distal myopathy with vocal cord and pharyngeal signs (ALS21<sup>◊</sup>)</td> <td>Autosomal dominant</td> <td>35 to 70</td> <td>Asymmetric lower legs and hands; variable dysphonia and dysphagia</td> <td>1 to 8 times normal</td> <td>Rimmed vacuoles</td> <td> <p>5q31</p> MATR3</td> </tr> <tr> <td>New Finnish distal myopathy (MPD3)</td> <td>Autosomal dominant</td> <td>&gt;30</td> <td>Hands or anterior lower legs</td> <td>1 to 4 times normal</td> <td>Dystrophic; rimmed vacuoles, eosinophilic inclusions</td> <td>8p22-q11</td> </tr> <tr> <td>Williams distal myopathy (MPD4)</td> <td>Autosomal dominant</td> <td>20 to 40</td> <td>Hands</td> <td>Normal to 6 times normal</td> <td>Normal, or myopathic changes</td> <td> <p>7q32.1</p> FLNC</td> </tr> <tr> <td>Distal myopathy with pes cavus and areflexia (vacuolar neuromyopathy)</td> <td>Autosomal dominant</td> <td>15 to 50</td> <td>Legs: lower anterior and posterior; dysphonia and dysphagia</td> <td>2 to 6 times normal</td> <td>Dystrophic, rimmed vacuoles</td> <td>19p13.3</td> </tr> <tr> <td>Distal myopathy with rimmed vacuoles </td> <td>Autosomal dominant</td> <td> 35 to 60</td> <td>Anterior lower legs</td> <td>1 to 2 times normal</td> <td>Dystrophic, rimmed vacuoles</td> <td> <p>5q35.3</p> <p>SQSTM1</p> </td> </tr> </tbody></table></div><div class="graphic_footnotes"><p>ANO5: anoctamin 5 gene; DYSF: dysferlin gene; FLNC: filamin C, gamma gene; GNE: UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase gene; LDB3: LIM domain binding 3 gene; LGMD, limb-girdle muscular dystrophy; MATR3: matrin 3 gene; MPD1: distal myopathy 1; MPD2: distal myopathy 2; MPD3: distal myopathy 3; MPD4: distal myopathy 4; MYH7: myosin heavy chain 7 cardiac muscle beta gene; MYOT: myotilin gene; SQSTM1: sequestosome 1 gene; TIA1: TIA1 cytotoxic granule-associated RNA binding protein gene; TTN: titin gene.<br/>* Autosomal recessive hereditary inclusion body myopathy (HIBM or IBM2), also known as quadriceps sparing myopathy, and Nonaka distal myopathy are allelic disorders caused by mutations in the GNE gene.<br/>¶ LGMD type R2 (previously LGMD 2B) co-localizes with Miyoshi muscular dystrophy 1.<br/>Δ LGMD R12 (previously LGMD 2L) co-localizes with Miyoshi muscular dystrophy 3.<br/><font class="lozenge">◊</font> In some families, MATR3 mutations cause familial amyotrophic lateral sclerosis.</p></div><div class="graphic_reference">Additional data from: 

<ol>
<li>Suominen T, Udd B, Hackman P. Udd distal myopathy. GeneReviews. www.ncbi.nlm.nih.gov/books/NBK1323/ (Accessed on January 18, 2011).</li>
<li>Guergueltcheva V, Peeters K, Baets J, et al. Distal myopathy with upper limb predominance caused by filamin C haploinsufficiency. Neurology 2011; 77:2105.</li>
<li>Schessl J, Kress W, Schoser B. Novel ANO5 mutations causing hyper-CK-emia, limb girdle muscular weakness and Miyoshi type of muscular dystrophy. Muscle Nerve 2012; 45:740.</li>
<li>Hackman P, Sarparanta J, Lehtinen S, et al. Welander distal myopathy is caused by a mutation in the RNA-binding protein TIA1. Ann Neurol 2012; 73:500.</li>
<li>Johnson JO, Pioro EP, Boehringer A, et al. Mutations in the Matrin 3 gene cause familial amyotrophic lateral sclerosis. Nat Neurosci 2014; 17:664.</li>
<li>Bucelli RC, Arhzaouy K, Pestronk A, et al. SQSTM1 splice site mutation in distal myopathy with rimmed vacuoles. Neurology 2015; 85:665.</li>
<li><a href="http://www.ncbi.nlm.nih.gov/omim" target="_blank">Online Mendelian Inheritance in Man</a>.</li></ol>Adapted with permission from: Orrell RW, Darras BT, Griggs RC. Facioscapulohumeral dystrophy, scapuloperoneal syndromes, and distal myopathies. In: Neuromuscular disorders in infancy, childhood, and adolescence: A clinician's approach, Jones HR, De Vivo DC, Darras BT (Eds), Butterworth Heinemann, Philadelphia 2003. p.701. Copyright © 2003 Elsevier.</div><div id="graphicVersion">Graphic 51980 Version 15.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
